Tag: Leadiant
AMSTERDAM, THE NETHERLANDS: The District Court of Rotterdam has rejected the appeal of pharmaceutical company Leadiant against the 2021 decision of the Netherlands Competition...
PAF welcomes the news that the Spanish competition authority has fined Leadiant €10,25 million
Farma ter Verantwoording -
AMSTERDAM: The Pharmaceutical Accountability Foundation (PAF), a group of legal and medical experts and public health advocates, today welcomes the news that the Spanish...
Martina Liccardo’s take on the role of the European Medicine Agency in Leadiant’s price misuse with CDCA
FtV Projectcoordinator -
As an international student I have always sought out opportunities to meet local people and to broaden my personal and professional network.
When provided with...
After Netherlands and Israel, now Italy: Leadiant fined for excessive price
FtV Projectcoordinator -
Bergeijk, June 2, 2022
The Italian Competition Authority (ICA) decided on 31 May that pharmaceutical company Leadiant has charged the Italian National Health Service excessive...
On 27 January we hosted the second part of our webinar series The Power of Law.
This second part was dedicated to presenting our...
On 17 november, Wilbert Bannenberg, chair of the Pharmaceutical Accountability Foundation, presented at the regional Access to Medicines Dialogue of the EU Alliance. The...
Dutch Competition Authority ACM honors PAFs enforcement request and fines pharmaceutical company Leadiant with €19.5 million
Farma ter Verantwoording -
Bergeijk, July 19, 2021
On September 7, 2018, the Pharmaceutical Accountability Foundation (PAF) submitted an enforcement request  for abuse of a dominant market position by...
The Pharmaceutical Accountability Foundation welcomes the news that the Amsterdam UMC (Amsterdam University Medical Centers) has resumed supplying Dutch patients with the rare disease...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022